PEBP1 and neoplasm: RKIP is further reported to be involved in the modulation of the response to immunotherapeutic drugs and immuno-mediated cytotoxicity, by functioning as an apoptosis inducer, causing re-sensitization of resistant tumour cells and host immunosurveillance [47,48].